Loading company
Just reported
Q3 FY2027 results
From Usana Health Sciences's results release of November 3, 2026. These are the company's first figures; its 10-Q or 10-K replaces them when filed.
Revenue
Actual
$205.9M
-3.6% y/y
-7.8% q/qGuided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →Keep exploring
The themes Usana Health Sciences is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Highest-graded in Packaged Foods
Graded A or B and worth $2B or more: A first, then the largest.
SJMJ M Smucker Co$14.2BA
MKCMccormick & Company, Incorporated$12.7BA+
FRPTFreshpet, Inc.$3.3BA
DARDarling Ingredients Inc.$8.7BB+
POSTPost Holdings, Inc.$3.6BB
Grade rose recently in Consumer Staples
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
BUDAnheuser-Busch InBev SAJul 30, 2026BAGraded B, now A
MDLZMondelez International, Inc.Oct 29, 2026CAGraded C, now A
HSYHershey Co.Oct 29, 2026BAGraded B, now A
SYYSysco CorporationNov 4, 2026BAGraded B, now A
ELFe.l.f. Beauty, Inc.Nov 4, 2026BAGraded B, now A
Built from Usana Health Sciences, Inc.’s own filings with the U.S. Securities and Exchange Commission (SEC). Figures are as reported, with per-share history restated onto today’s share basis. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.
